Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 548.10
-4.60 (-0.83%)
Oct 7, 2026, 3:29 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 17.78 billion as of October 7, 2026. That makes Krsnaa Diagnostics the world's 21,501st most valuable company and 1,319th in India. Its market cap has decreased by 29.54% in one year.
Market Cap
17.78B
Enterprise Value
19.52B
Revenue
8.41B
Global Rank
Country Rank
#1,319 India
PE Ratio
18.47
ChartMarket Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 17.78B, a decrease of -42.63%. That is a compound annual growth rate of -10.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 17.78B | -24.02% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 2.44T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.15T |
| Panacea Biotec | 21.45B |
| Windlas Biotech | 21.01B |
| Beta Drugs | 20.31B |
| Tarsons Products | 17.87B |